^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    linavonkibart (SRK-181)

    i
    Other names: SRK-181, SRK 181, Latent TGFβ1 Context independent, SRTβ1-Ab3, TGF-beta 1 niche activators
    Associations
    News

    Trials

    Company:
    Scholar Rock
    Drug class:
    TGF-β1 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) (NCT04291079)
    Phase 1
    Scholar Rock, Inc.
    Active, not recruiting
    Last update posted :
    01/11/2024
    Initiation :
    04/23/2020
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    EGFR • ALK
    |
    linavonkibart (SRK-181)